Highlights

  • NIB Holdings shares dropped 16.01% over six months but gained 16.76% over five years.
  • Analysts assign a BUY rating with a consensus target price of AUD 7.67, implying nearly 19.2% upside.
  • NIB Group agreed to sell its World Nomads international travel insurance business to IMG for AUD 67.5M.

NIB Holdings Ltd (ASX:NHF) opened at 6.38 AUD today, showing a minimal intraday change of -0.0050 AUD (0.078%). The stock traded high in the morning after the announcement but couldn’t hold its position as the day passed.

Over recent periods, the stock has experienced fluctuations: a decline -1.01% in the past five days, -5.70% over the past month, and -16.01% across the last six months.

Year-to-date, the shares have decreased by-7.21%, reflecting the broader pressures on the Australian insurance sector. Despite recent declines, NIB shares have recorded gains of 8.23% over the past year and 16.76% over the past five years. The all-time share price growth stands at 414.11%, underscoring the company’s long-term market performance.

Broker Ratings and Market View
As of 13 Feb 2026, Refinitiv data shows, brokerage assessments continue to highlight potential upside for NIB Holdings. Analysts maintain a BUY rating, with a consensus target price of 7.67 AUD. This suggests a potential gain of approximately 19.2% from current levels.

The rating reflects NIB’s established position in the Australian health insurance market and steady membership growth, despite regulatory and competitive pressures affecting the sector.

Impact of Recent Strategic Move
NIB Group recently signed an agreement to sell its World Nomads international travel insurance business to International Medical Group (IMG), a subsidiary of SiriusPoint Ltd (NYSE:SPNT), for AUD 67.5M, with net cash proceeds expected at around AUD 70M. The divestment excludes NIB’s Australian and New Zealand travel insurance assets.

The sale aligns with NIB’s focus on core health insurance and adjacent businesses. FY25 contributions from nib Travel were AUD 6.7M to the Group’s total underlying operating profit of AUD 239.2M. NIB will provide transitional support to IMG, with the transaction expected to close in CY26, pending regulatory approvals.

The divestment, combined with ongoing portfolio reviews, could influence investor sentiment and share price dynamics, particularly in the short term, as the market reacts to the company’s refined strategic focus.

NIB Holdings’ shares reflect a mixed performance: moderate recent declines alongside long-term gains. Brokerage ratings indicate potential upside, while the World Nomads divestment signals strategic portfolio adjustments. Market participants will be watching share movements closely ahead of 1H26 results to gauge the impact of these decisions on profitability and shareholder value.

FAQs
Q1. What is the current brokerage rating for NIB Holdings?
Analysts maintain a BUY rating with a consensus target price of 7.67 AUD, suggesting 19.2% upside.

Q2. How has the share performed over the past six months?
Shares declined by 16.01% over six months, while long-term gains over five years remain 16.76%.

Q3. What recent divestment did NIB announce?
NIB agreed to sell its World Nomads international travel insurance business to IMG for AUD 67.5M.